MedPath

Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS)

Phase 3
Completed
Conditions
Atrial Fibrillation
Registration Number
NCT00070655
Lead Sponsor
Sanofi
Brief Summary

This trial will include patients who have a heart condition called atrial fibrillation. Atrial fibrillation is an abnormal rhythm (irregular beat) in the heart. Patients with atrial fibrillation have an increased chance for a blood clot to form in the heart and move to other blood vessels in the body and cause obstruction. This obstruction may damage tissue. For example, a blood clot plugging a vessel in the brain could cause a stroke. Therefore, patients with atrial fibrillation may be given anticoagulant (blood-thinning) tablets such as warfarin or acenocoumarol.

The purpose of this study is to compare the safety and effectiveness of a new injectable anticoagulant drug that is administered once weekly, SR34006 with warfarin or acenocoumarol tablets.

Assignment to either SR34006 Injection or vitamin K antagonist (warfarin or acenocoumarol) tablets will be purely by chance and will be known by both patients and their doctors.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
4673
Inclusion Criteria
  • ECG-documented atrial fibrillation (AF) and an indication for long-term vitamin K antagonist (VKA) therapy based on the presence of at least one of the following risk factors:

    1. previous ischemic stroke, transient ischemic attack (TIA) or systemic embolism
    2. hypertension requiring drug treatment
    3. left ventricular dysfunction (left ventricular ejection fraction <45% or symptomatic congestive heart failure)
    4. age >75 years
    5. age between 65-75 years plus diabetes mellitus, or
    6. age between 65-75 years plus symptomatic coronary artery disease (previous myocardial infarction (MI) or angina pectoris)
  • Written informed consent

Exclusion Criteria
  • Legal lower age limitations (country specific)
  • Indication for VKA other than AF, including prosthetic heart valves, venous thromboembolism, and planned cardioversion
  • Transient AF caused by a reversible disorder
  • Active bleeding or high risk of bleeding
  • Recent (<15 days) or anticipated invasive procedures with potential for uncontrolled bleeding, including major surgery
  • Participation in another pharmacotherapeutic study within the prior 30 days
  • Creatinine clearance <10 mL/min, severe hepatic disease, or bacterial endocarditis
  • Uncontrolled hypertension: systolic blood pressure > 180 mm Hg and/or diastolic blood pressure > 110 mm Hg
  • Pregnancy or childbearing potential without proper contraceptive measures
  • Breastfeeding
  • Any other contraindication listed in the labeling of warfarin or acenocoumarol

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Composite of all strokes and non-CNS systemic embolism.
Secondary Outcome Measures
NameTimeMethod
Separate components of the primary study outcome.

Trial Locations

Locations (67)

Saskatoon Medical Specialists

🇨🇦

Saskatoon, Saskatchewan, Canada

Health Care Corporation of St. John's Health Sciences Centre

🇨🇦

St. John's, Newfoundland and Labrador, Canada

Yorkton Regional Health Centre

🇨🇦

Yorkton, Saskatchewan, Canada

Royal University Hospital

🇨🇦

Saskatoon, Saskatchewan, Canada

Moose Jaw Cardiac Centre

🇨🇦

Moose Jaw, Saskatchewan, Canada

Dr. Joesph J. Javier

🇨🇦

Yorkton, Saskatchewan, Canada

North Broward Hospital District Cardiovascular Research Institute

🇺🇸

Fort Lauderdale, Florida, United States

Swedish Medical Center

🇺🇸

Seattle, Washington, United States

Marshfield Clinic

🇺🇸

Marshfield, Wisconsin, United States

St. Joseph's Hospital

🇺🇸

Marshfield, Wisconsin, United States

Denver Health and Hospital Authority Eastside Health Clinic

🇺🇸

Denver, Colorado, United States

Denver Health Medical Center

🇺🇸

Denver, Colorado, United States

Richard A. Levy, M.D.

🇺🇸

San Francisco, California, United States

Denver Health and Hospital Authority Adult Medicine Clinic

🇺🇸

Denver, Colorado, United States

Beacon Medical Research

🇺🇸

Indianapolis, Indiana, United States

South Texas Cardiovascular Consultants

🇺🇸

San Antonio, Texas, United States

LDS Hospital

🇺🇸

Salt Lake City, Utah, United States

Physicians Office Building (POB)

🇺🇸

Salt Lake City, Utah, United States

Kenneth W. Carr, M.D. Cardiology

🇺🇸

Oceanside, California, United States

IMG Healthcare, LLC

🇺🇸

New Orleans, Louisiana, United States

Cardiology Specialists of Orange County

🇺🇸

Santa Ana, California, United States

Southern Arizona Veterans Affairs Health Care System

🇺🇸

Tucson, Arizona, United States

Saguaro Clinical Research

🇺🇸

Tucson, Arizona, United States

Oracle Research, a Division of: The Heart Center, P.C.

🇺🇸

Huntsville, Alabama, United States

Arizona Heart Institute Mesa

🇺🇸

Mesa, Arizona, United States

Jerry L. Pettis VA Medical Center

🇺🇸

Loma Linda, California, United States

Cardiology, P.C.

🇺🇸

Birmingham, Alabama, United States

Office of Dr. Bowden, D.O.

🇺🇸

Healdsburg, California, United States

Cardiovascular Center of Sarasota

🇺🇸

Sarasota, Florida, United States

Wellington Green Family Practice

🇺🇸

Wellington, Florida, United States

New Mexico Heart Institute, PA

🇺🇸

Albuquerque, New Mexico, United States

Blackstone Cardiology Associates, P.C.

🇺🇸

Pawtucket, Rhode Island, United States

Cardiovascular Research Institute of Dallas, Inc./Cardiology and Internal Medicine Associates

🇺🇸

Dallas, Texas, United States

Heart & Vascular Clinic/Advanced Medical Research

🇺🇸

Covington, Louisiana, United States

Austin Heart, P.A.

🇺🇸

Austin, Texas, United States

Duke University Medical Center

🇺🇸

Durham, North Carolina, United States

The Oregon Health and Science University

🇺🇸

Portland, Oregon, United States

Cardiac Arrhythmia Trials

🇨🇦

Victoria, British Columbia, Canada

Inland Cardiology

🇺🇸

Spokane, Washington, United States

A.O. "Instituti Ospitalieri di Cremona"

🇮🇹

Cremona, Italy

Zoom International Inc.

🇨🇦

St. Jerome, Quebec, Canada

Academisch Ziekenhuis Maastricht

🇳🇱

Maastricht, Netherlands

Azienda Ospedaliera San Paolo

🇮🇹

Milano, Italy

Azienda Ospedaliera di Parma

🇮🇹

Parma, Italy

U.O. di Medicina Interna II

🇮🇹

Parma, Italy

Centro Emostasi e Trombosi

🇮🇹

Rimini, Italy

Freeman Hospital

🇬🇧

Newscastle Upon Tyne, United Kingdom

University Hospital of Wales

🇬🇧

Cardiff, United Kingdom

University of Glasgow

🇬🇧

Glasgow, United Kingdom

New Cross Hospital

🇬🇧

Wolverhampton, United Kingdom

Baystate Medical Center

🇺🇸

Springfield, Massachusetts, United States

University of New Mexico Hospital

🇺🇸

Albuquerque, New Mexico, United States

The Clinic (Lake Charles Medical & Surgical Clinic)

🇺🇸

Lake Charles, Louisiana, United States

Practice of James A. Underberg @ Murray Hill Medical Group

🇺🇸

New York, New York, United States

Concord Repartiation General Hospital

🇦🇺

Concord, Australia

McGuire VA Medical Center

🇺🇸

Richmond, Virginia, United States

Foothills Medical Centre

🇨🇦

Calgary, Alberta, Canada

Cardiology Consultant's Group

🇨🇦

Calgary, Alberta, Canada

University of Calgary

🇨🇦

Calgary, Alberta, Canada

West Coast Cardiology Research

🇨🇦

New Westminster, British Columbia, Canada

Specialists Internal Medicine

🇨🇦

Saskatoon, Saskatchewan, Canada

Aurora Denver Cardiology Associates

🇺🇸

Aurora, Colorado, United States

Jacksonville Center for Clinical Research

🇺🇸

Jacksonville, Florida, United States

Dr. M.P.J. Senaratne Professional Corporation

🇨🇦

Edmonton, Alberta, Canada

Florida Arrhythmia Consultants

🇺🇸

Fort Lauderdale, Florida, United States

Jacksonville Cardiovascular Clinic

🇺🇸

Jacksonville, Florida, United States

Heart Health Institute

🇨🇦

Calgary, Alberta, Canada

© Copyright 2025. All Rights Reserved by MedPath